Related Experiment Video
Updated: Aug 22, 2026
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
A systematic review and meta-analysis on impulse-control disorders in patients with pituitary adenomas exposed to
Rodrigo Bilbao1, José Serralunga1, Nicolás Loschiavo1
1Departamento de Fisiología, Facultad de Medicina, Universidad de Buenos Aires (UBA), Buenos Aires, Argentina.
Background:
Patients exposed to dopamine agonists (DAs) may develop impulse-control disorders (ICDs), as shown in Parkinson's Disease. Patients with pituitary adenomas treated with DAs may also have a higher frequency of ICDs.
Objective:
We compared the frequency of ICDs or impulsiveness in patients with pituitary adenomas treated with DAs versus patients with pituitary adenomas not exposed to DAs or healthy controls.
Methods:
Observational studies published in any language up to June 30th, 2026 were searched for in PubMed, EMBASE, EBSCO, LiLACS, SCOPUS, and WOS databases. We compared the occurrence of ICDs and impulsiveness scale scores between patients exposed to and not exposed to DAs.
Results:
Out of 14 studies identified, 10 reported the association between DAs and ICDs, and 6 reported the impact on the Barratt Impulsiveness Scale. DAs were significantly associated with ICDs (random-effects models, OR, 95% CI: 2.39, 1.78-3.21; I2 = 0%, n=1247; p<0.01) regardless of age, sex, cabergoline dose, or treatment duration. There were no indications of publication bias. Exposure to DAs was significantly associated with hypersexuality (3.11, 1.93-5.02, p<0.01, I2 = 0%) and punding (2.53, 1.34-4.78, p<0.01, I2 = 27.6%), but not with pathological gambling (1.94, 0.84-4.49, p=0.12, I2 = 0%) or compulsive shopping (1.46, 0.59-3.36, p=0.41, I2 = 61.3%).
Conclusion:
Patients with pituitary adenomas treated with DAs showed a higher frequency of ICDs. Studies to confirm these findings and investigate the risk factors for ICDs in this patient population are warranted.
Related Concept Videos
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
01:24Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:30Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
01:29Drugs Affecting Neurotransmitter Synthesis
01:25Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...